The association of steatotic liver disease with cardiometabolic criteria and cardiovascular disease risk in a large cohort of people living with human immunodeficiency virus
CMRF are very common in PWH, with MASLD or MetALD frequently having multiple CMRF. The PREVENT scores showed higher 10-year CVD, ASCVD, and heart failure risk in those with MASLD versus those without SLD.
Authors
- Sonya L. Heath (ORCID: https://orcid.org/0000-0002-3826-0954)
- Samer Gawrieh (ORCID: https://orcid.org/0000-0002-2056-4909)
- Rohit Seth Loomba (ORCID: https://orcid.org/0000-0002-4845-9991)
- Mark Sulkowski (ORCID: https://orcid.org/0000-0002-2145-6352)
- Jordan E. Lake (ORCID: https://orcid.org/0000-0002-0640-5514)
- Jennifer C. Price (ORCID: https://orcid.org/0000-0002-3825-5696)
- Susanna Naggie (ORCID: https://orcid.org/0000-0001-7721-6975)
- Holly Crandall
- Naga Chalasani (ORCID: https://orcid.org/0000-0003-4082-3178)
- Richard K. Sterling (ORCID: https://orcid.org/0000-0002-8637-2475)
- Laura Wilson (ORCID: https://orcid.org/0000-0003-2858-9358)
Institutions
- Johns Hopkins University (US)
- Duke University (US)
- University of California, San Francisco (US)
- Virginia Commonwealth University (US)
- University of Alabama at Birmingham (US)
- University of California San Diego (US)
- Indiana University (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- American Journal of Preventive Cardiology
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1016/j.ajpc.2025.101330
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35